BioCentury
ARTICLE | Company News

Unigene submits nasal calcitonin NDA

March 6, 2003 8:00 AM UTC

UGNE submitted to the FDA an NDA for its Fortical nasal calcitonin to treat osteoporosis. Upsher-Smith Laboratories (Minneapolis, Minn.) has exclusive U.S. marketing and distribution rights to the com...